The IRCCS Istituto di Ricerche Farmacologiche Mario Negri ( is a non-profit bi-omedical research organization. The Institute’s research programs span from the molecular level to the whole human being and to populations and the findings help build up the basis for developing new drugs, and making existing ones more effective, safe and appropriately used and developing and evaluating non-pharmacological treatments.
IRFMN has consolidated experience in pharmacoepidemiological research, development, coordina-tion and analyses of randomised clinical trials and observational studies, and in the quality assess-ment of health services and interventions. In particular the Department of Neuroscience, to which belonging the Laboratories participating in this Project, has been involved in numerous FP7 European Consortia in the area of Alzheimer's disease and other neurological disorders at the clinical and ex-perimental level (IMI-Pharmacog; NILVAD, NAD, EUROMOTOR, EPITARGET).
In FOCUS project, IRFMN is responsible of the task 4.2. (i, i and iiii). Moreover, IRFMN will lead task 5.2 and contribute to task 5.1.